Melanotan 1 purity is a critical parameter for laboratory investigators evaluating melanocortin receptor signaling and pigmentation pathways in preclinical models. Maintaining high chemical purity ensures consistent receptor affinity, prevents off-target cellular toxicity, and guarantees reproducible experimental outcomes across in vitro and animal assays.
Melanotan 1 purity is a critical parameter for laboratory investigators evaluating melanocortin receptor signaling and pigmentation pathways in preclinical models. Maintaining high chemical purity ensures consistent receptor affinity, prevents off-target cellular toxicity, and guarantees reproducible experimental outcomes across in vitro and animal assays.
In laboratory settings, Melanotan 1 purity refers to the percentage of intact, correctly sequenced peptide sequence—specifically [Nle4, D-Phe7]-α-MSH—relative to synthesis byproducts, truncated sequences, enantiomeric impurities, and chemical contaminants. High-purity Melanotan 1 ensures that experimental observations in cell cultures or tissue models stem solely from target melanocortin receptor binding.
When purchasing compounds for bioassays, research teams rely on rigorous quantitative testing to ensure lot-to-lot consistency. For comprehensive catalog selections of research-grade compounds, investigators can review our full all peptides inventory.
Because synthetic peptide manufacturing via solid-phase peptide synthesis (SPPS) can generate deletion sequences or side-chain modifications, verifying raw material composition via chromatographic and spectroscopic methods is essential prior to reconstituting material for controlled laboratory trials.
Melanotan 1 (Afamelanotide) is a synthetic tridecapeptide analog of endogenous alpha-melanocyte-stimulating hormone (α-MSH). Chemically structured with the amino acid sequence Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2, it incorporates strategic structural modifications—specifically substitution of norleucine at position 4 and D-phenylalanine at position 7—to enhance enzymatic stability against aminopeptidases.
Preclinical studies suggest that these structural enhancements significantly increase the compound's half-life in physiological buffers compared to native α-MSH. In vitro receptor binding assays demonstrate that Melanotan 1 acts as a potent non-selective agonist across several melanocortin receptor subtypes, exhibiting high affinity for the MC1R receptor expressed on melanocytes.
Investigators interested in the broader biochemical family can consult our melanocortin research peptides overview to analyze structural variations across synthetic α-MSH derivatives.
In vitro data indicate that Melanotan 1 stimulates melanogenesis through the activation of the transmembrane melanocortin 1 receptor (MC1R). Upon receptor binding, the compound stimulates adenylate cyclase, raising intracellular cyclic adenosine monophosphate (cAMP) levels. This signaling cascade upregulates microphthalmia-associated transcription factor (MITF), subsequently increasing the expression of tyrosinase and tyrosinase-related proteins.
Animal study models, particularly rodent assays, have evaluated the peptide's capacity to induce eumelanin synthesis independent of ultraviolet radiation exposure. Researchers utilize high-purity Melanotan 1 to isolate these intracellular signaling pathways without interference from degraded peptide fragments or residual coupling reagents.
Understanding these pathways provides baseline metrics for studying photoprotection mechanism dynamics and cutaneous cell responses to melanocortin receptor activation in controlled laboratory settings.
To establish Melanotan 1 purity beyond standard theoretical values, analytical laboratories utilize Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) paired with Electrospray Ionization Mass Spectrometry (ESI-MS). RP-HPLC separates the primary peptide from related substances based on hydrophobic interactions with a C18 stationary phase, yielding a percentage peak area representing purity.
A valid Certificate of Analysis (COA) must reflect a target main peak area exceeding 98.0% or 99.0%. Concurrently, mass spectrometry confirms the precise molecular weight of the target peptide (theoretical monoisotopic mass ~1646.85 Da), verifying the absence of incomplete sequences or unintended adducts.
To examine how analytical methodologies are documented across various target molecules, researchers can explore our published analytical guides within the PX1 research library.
Beyond chemical sequence purity, bioburden and bacterial endotoxin levels present significant variables in cell culture and preclinical research. Bacterial lipopolysaccharides (LPS) can trigger non-specific inflammatory signaling through Toll-like receptor 4 (TLR4), confounding assays evaluating cAMP activation or gene expression.
High-quality research reagents undergo quantitative Chromogenic Recombinant Factor C (rFC) or Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain strictly below <0.5 EU/mg (and frequently <0.1 EU/mg). Maintaining minimal endotoxins ensures that cellular responses observed during in vitro exposure reflect true peptide-receptor dynamics.
For large-scale screening protocols requiring stringent lot control across multiple operational batches, institutional accounts can review options via our wholesale lab portal.
When designing melanocortin receptor studies, researchers frequently compare Melanotan 1 against other synthetic analogs within the class. While Melanotan 1 is a linear tridecapeptide designed specifically to mimic α-MSH activity on skin pigmentation pathways, cyclic analogs exhibit distinct selectivity profiles and binding kinetics.
For example, evaluating Melanotan 2 purity reveals a cyclic heptapeptide structure that crosses biological membranes differently and demonstrates broader activity across central melanocortin receptors (MC3R and MC4R). Similarly, investigating PT-141 research highlights a metabolite analog focused heavily on central nervous system MC3R/MC4R pathways rather than primary epidermal MC1R pigmentation models.
Selecting the appropriate peptide relies on matching structural geometry, cyclic versus linear stability, and receptor sub-type selectivity to the specific hypothesis under investigation.
Melanotan 1 is supplied as a sterile, lyophilized white powder to maximize shelf stability. Proper reconstitution protocols are critical to maintaining structural integrity and preventing peptide aggregation prior to assay execution.
In vitro researchers typically reconstitute the lyophilized cake using sterile, laboratory-grade solvents such as bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Gentle rotation of the vial is recommended; vigorous vortexing or agitation must be avoided, as shear forces can disrupt secondary structures and lead to irreversible precipitation.
For long-term experimental series, master stock solutions should be prepared in concentrated aliquots to minimize repetitive thermal cycling during working solution preparation.
Lyophilized Melanotan 1 exhibits high stability when stored under controlled atmospheric and thermal conditions. For long-term preservation (12 to 24 months), vials should be stored at -20°C or -80°C in a desiccated environment to prevent moisture accumulation.
Once reconstituted into aqueous solution, the peptide is susceptible to hydrolysis and oxidation over extended periods. Reconstituted stock solutions stored at 2°C to 8°C should generally be utilized within 20 to 30 days. Avoiding repeated freeze-thaw cycles is essential, as phase transitions generate localized concentration gradients and ice crystal formation that degrade peptide bonds.
PX1 Research enforces strict quality control protocols to supply USA-manufactured compounds that meet high scientific standards. Every lot of Melanotan 1 undergoes independent ISO 17025 laboratory testing to verify sequence identity, chromatographic purity, and freedom from heavy metal and bacterial contamination.
Each shipment includes lot-traceable analytical documentation, ensuring full transparency for academic, biotechnology, and institutional laboratories. By combining GMP-compliant manufacturing environments with same-day dispatch from our California and Arizona fulfillment centers, PX1 Research provides researchers with reliable reagents for preclinical investigation.
What is the typical HPLC purity specification for Melanotan 1 at PX1 Research?
PX1 Research specifies a minimum RP-HPLC purity of ≥98.0% for Melanotan 1, with lot-specific Certificates of Analysis frequently documenting purity levels exceeding 99.0%.
How is Melanotan 1 sequence identity confirmed?
Identity is confirmed using Mass Spectrometry (ESI-MS or MALDI-TOF) to verify that the observed molecular weight matches the theoretical molecular mass of 1646.85 Da.
What endotoxin threshold is maintained for research-grade peptides?
PX1 Research enforces an endotoxin limit of <0.5 EU/mg (verified via LAL assay) to ensure suitability for sensitive cell culture and in vitro applications.
Which solvent is recommended for reconstituting Melanotan 1 in laboratory settings?
Reconstitution is typically performed using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the specific cell culture or assay buffer requirements.
How should reconstituted Melanotan 1 stock solutions be stored?
Reconstituted liquid stock solutions should be stored at 2°C to 8°C for short-term use (up to 30 days) or aliquoted and stored at -20°C to -80°C to avoid multiple freeze-thaw cycles.
What is the molecular difference between Melanotan 1 and endogenous α-MSH?
Melanotan 1 substitutes native amino acids at positions 4 and 7 with norleucine and D-phenylalanine, respectively, significantly increasing resistance to enzymatic degradation.
Are PX1 Research compounds suitable for human clinical use?
No. All compounds supplied by PX1 Research are strictly for laboratory research, in vitro, and preclinical research use only by qualified scientific personnel.
Where are PX1 Research compounds manufactured and shipped from?
All peptides are USA-manufactured in state-of-the-art facilities and dispatched same-day (Monday–Friday) from facility hubs located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.